What's New

On 27, August 2024, the Finnish Competition and Consumer Authority (FCCA) approved the merger of Mehiläinen and Docrates Cancer Center....

Docrates treats metastatic colorectal cancer in a personalised way, and its treatment recommendations are based on the latest research and...

In 2023, Docrates Cancer Center promoted its strategy by investing in larger facilities, developing services related to the early detection...

Docrates Cancer Center, which specialises in the diagnostics, treatment and monitoring of cancer, becomes part of Mehiläinen through an acquisition...

In the 2020s, about 1,000 Swedish patients have received cancer treatment at the private Docrates Cancer Center in Finland. More...

Docrates Cancer Center has been treating Finnish and international patients in Helsinki for more than 15 years. In 2023, the...

Riikka Talsi, M.Sc. (Tech), who defended her doctoral thesis at Aalto University School of Science, Department of Industrial Engineering and...

In early 2024, Docrates Cancer Center is strengthening its service package for early cancer detection and diagnostics by launching endoscopy...

Docrates Cancer Center, a Finnish private hospital specialising in cancer treatment and diagnostics, has now opened its MyDocrates patient service...

Jenni Marko, M.Sc. (Econ.), has been appointed as the HR Director of Docrates Cancer Center and a member of the...

The service offering of Docrates Cancer Center becomes even more diverse, especially for potential cancer patients who need early-stage diagnostics....

On 26 October 2023, the Finnish Research Professionals of the Year were honoured at the Clinical Trials Forum. Finnish researcher...